Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

We then selected the top 11 with the highest number of hedge fund holders as of Q4 2024 ... Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases. The company specializes ...

The March 19 edition of the SBJ Tech newsletter features a chat with NCAA VP, Chief Technology Officer John Macrina on his ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...

Inc. , today announced a definitive merger agreement under which Bristol Myers Squibb ("BMS") will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash ...

We are headquartered at the Empire State Building in New York City and are investigating 2seventy bio, Inc. (NASDAQ: TSVT), relating to the proposed merger with Bristol Myers Squibb.

Redwire Corporation (NYSE: RDW, the "Company"), a leader in space infrastructure for the next generation space economy, today ...

In the event that a secondary malignancy occurs, contact Bristol-Myers Squibb at 1-888-805-4555 for ... INVESTORS AND SECURITY HOLDERS ARE URGED TO CAREFULLY READ BOTH THE TENDER OFFER MATERIALS ...